Related Experiment Video
Updated: Jan 14, 2026

Extraction of Histones from Clinical Specimens for Epigenetic Profiling by Mass Spectrometry
Published on: November 21, 2025
Insight into the mechanisms and dysregulation of KMT5C-H4K20me3 in cancer
Jihye Son1,2, Andrea L Kasinski1,2
1Department of Biological Sciences, Purdue University, West Lafayette, IN, USA.
Abstract:
KMT5C-mediated histone H4 lysine 20 trimethylation (H4K20me3) has traditionally been linked to heterochromatin formation and maintenance, playing a crucial role in maintaining genome integrity. Emerging evidence, however, indicates that perturbations of KMT5C-H4K20me3 are also implicated in various cancers, positioning KMT5C-H4K20me3 as a promising target for anti-cancer therapies. Despite this, the precise mechanisms underlying KMT5C recruitment to its genomic targets and the specific genes it regulates remain poorly understood. In this review, we explore the dysregulation of KMT5C-mediated H4K20me3 in cancer, providing a comprehensive overview of its known functions. We also highlight recent findings that suggest a novel, non-canonical pathway for H4K20me3 deposition by KMT5C, and, while early on, insight into future opportunities for therapeutic intervention.
Insights
KMT5C-mediated histone H4 lysine 20 trimethylation (H4K20me3) is crucial for genome integrity but also implicated in cancer. This review explores its role in cancer and potential new therapeutic strategies.
Area of Science:
- Epigenetics and Gene Regulation
- Cancer Biology
- Molecular Oncology
Background:
- Histone H4 lysine 20 trimethylation (H4K20me3) mediated by KMT5C is traditionally associated with heterochromatin and genome stability.
- Recent studies link KMT5C-H4K20me3 dysregulation to various cancers, highlighting its therapeutic potential.
- The exact mechanisms of KMT5C recruitment and gene regulation are not fully understood.
Purpose of the Study:
- To review the role of KMT5C-mediated H4K20me3 in cancer.
- To provide a comprehensive overview of KMT5C functions and dysregulation in oncogenesis.
- To highlight novel findings and potential therapeutic interventions.
Main Methods:
- Literature review of existing studies on KMT5C and H4K20me3.
- Analysis of emerging evidence on KMT5C's role in cancer.
- Synthesis of current knowledge on H4K20me3 deposition pathways.
Main Results:
- KMT5C-H4K20me3 is implicated in cancer development and progression.
- A novel, non-canonical pathway for H4K20me3 deposition by KMT5C is suggested.
- KMT5C presents a potential target for anti-cancer therapies.
Conclusions:
- KMT5C-mediated H4K20me3 plays a dual role in genome integrity and cancer.
- Further research into KMT5C recruitment and regulation is needed.
- Exploration of KMT5C as a therapeutic target offers promising avenues for cancer treatment.
More Related Videos
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Spreading of Chromatin Modifications
Writers
The writer...

